Insulin Aspart Protamine And Insulin Aspart Injection, Suspension
Product Images NDC 70518-3236

1 FDA label image from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Insulin Aspart Protamine And Insulin Aspart (NDC 70518-3236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Insulin Aspart Protamine Insulin Aspart 70 30 100 Units mL(u 100) 70518 3236 00)

Mm1 (Insulin Aspart Protamine   Insulin Aspart 70 30 100 Units   mL(u 100) 70518 3236 00)
Label for Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension, 100 Units/mL (U-100) in a package of 5 x 3mL prefilled pens. The label states it is for single patient use, subcutaneous injection, and warns to use with specific disposable needles and to avoid freezing. Manufactured by Novo Nordisk Inc., repackaged by RemedyRepack Inc., Indiana, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.